The early effects and some of the later sequelw of adrenalectomy for Cushing's syndrome are well known (Welbourn 1969) , but the late results of a complete series of patients has not, so far as we know, been reported since the advent of cortisone made adrenalectomy relatively safe. We report here the results after five years in our first 35 patients, after ten years in our first 20, and after fifteen years in our first 8.
The response to treatment depends very much on the nature of the underlying lesion (Table 1) . Of our 35 patients 3 had adrenal adenomas, which were removed surgically. They all did well and are in remission at 5, 7 and 14 years respectively. Four had adrenal carcinomas and all fared badly, none of the 4 patients living for more Benign adenoma discovered at autopsy 2 Jr2 Adrenal hyperplasia without evidence 18 J of tumour elsewhere * 3 of these were invasive * 1 of these was invasive than a year. One patient had a bronchial carcinoma and died in a few weeks without treatment.
Pituitary-adrenal
Hyperfunction Twenty-seven patients had pituitary-adrenal hyperfunction and bilateral adrenal hyperplasia. It is known from post-mortem evidence that about half such patients have pituitary adenomas, many of which are small and unrecognizable during life. It is known also from clinical experience that some of them are large, that some reveal themselves only after adrenalectomy, and that some are locally malignant and invade the tissues around the pituitary in an insidious and lethal manner.
Pituitary tumours: Of our 27 patients, 9, or onethird, had pituitary tumours. Four were apparent initially and 3 of these became invasive later. Three manifested themselves some time after adrenalectomy and one of these was invasive. Two small benign ones were found at autopsy. We have lost trace of one patient, but the remaining 17 have not yet shown any evidence of pituitary tumours during 5-15 years of observation.
Our policy from the beginning has been to treat patients with obvious pituitary tumours by a direct surgical attack on the pituitary and the remainder by bilateral adrenalectomy. The 4 patients with obvious pituitary tumours initially had various combinations of internal irradiation and surgical hypophysectomy, but only one, who had a simple tumour, had a good remission, which has lasted for ten years. Iln the other 3 the syndrome was not controlled adequately and adrenalectomy was required subsequently. Their tumours became invasive later and all 3 patients were dead within three years.
Bilateral Adrenakctomy
We were then left with 23 patients with pituitaryadrenal hyperfunction, without evidence of pituitary tumours, and we planned to treat them all by bilateral adrenalectomy. One refused operation and then had a spontaneous remission. (This patient we lost track of after a year.) The remaining 22 had bilateral adrenalectomy, which was subtotal in 21 and total in one. Subtotal adrenalectomy involved removal of the whole of one gland, nearly always the right, and about nine-tenths of the other, usually in two stages.
All those who lived for more than a few months had good remissions and lost the florid features of Cushing's syndrome. Ten patients, however, died at various times after operation, one inexplicably within a few days. Six died from cardiovascular accidents, 4 within one year of operation, one after two years and one after thirteen years. One died from an invasive tumour of the pituitary after three and a half years, and 2 from meningoencephalitis after one year and four years respectively.
Signs of pituitary tumours developed in 3 of the 22 patients after adrenalectomyan incidence of 14%. In all 3 there was widespread pigmentation within eighteen months of operation and in 2 the pituitary fossm were enlarged within three years. One tumour, which was invasive, ruptured and caused death after three and a half years. A benign one was removed surgically and the pigmentation faded. The presence of the third tumour is presumed, but not proved. The patient, who was 11 at the time of operation, has never had any enlargement of the fossa. He has had a normal puberty and is now, eight years after operation, still deeply pigmented.
We know that pituitary tumours can remain dormant for a very long time because we found a small one at autopsy thirteen years after adrenalectomy. But in our series all those which revealed themselves during life did so within three years.
Adrenal Function and Recurrence after
Subtotal Adrenaketomy Our hope was that subtotal adrenalectomy would restore normal adrenal function. In fact it has not done so. Of the 20 patients without pituitary tumours initially, who survived operation, 8 (40%) were weaned off cortisone at first, but their steroid excretion was low and could not be stimulated by ACTH. Two of these patients developed recurrence of the syndrome. The first recurrence was in a woman of 44, six years after operation. The adrenal remnant was reexplored, but could not be found, and she then underwent remission again spontaneously and remains well nine years later. The second oocurred in a man of 32, eleven years after operation. The adrenal remnant, which weighed 8 g, was removed totally and he is now well, on cortisone, four years later.
Twelve patients (60%) could not be weaned off cortisone at first. One of them, who failed to take her cortisone when she fell ill, had an acute adrenal crisis after five years. After nine years she had a temporary recurrence which settled down again when cortisone was stopped. She died from coronary occlusion four years later.
There were, then, 3 recurrences in 20 patientsor 15%. All were treated effectively or settled down on their own. Only three, or one-third, of the 9 patients who survived ten years remained off cortisone for this period without showing recurrence.
Three further patients with invasive pituitary tumours underwent subtotal adrenalectomy when attacks on the pituitary had failed to control the syndrome. One died from a cardiovascular accident before the effect could be assessed. The other 2 failed to respond and in one of them the adrenal remnant, which had increased to 10 g, was removed four months later. The patient then underwent remission. The other patient, mentioned earlier, who died from an invasive tumour after subtotal adrenalectomy, did not have any recurrence of Cushing's syndrome when the tumour enlarged. In our experience, then, subtotal adrenalectomy failed to control the syndrome in half the patients with invasive pituitary tumours.
Our feeling about subtotal adrenalectomy now is that, since so few patients achieve independence from cortisone and some develop recurrence, and since close personal supervision is required during the weaning period, it is neither safe nor worth while unless the patients live close enough to be seen regularly. One of us (D A D M) continues to use the subtotal operation for the majority of patients treated in Belfast, because they live close at hand; the other (R B W) has abandoned it in favour of total adrenalectomy, and accepts the need for permanent replacement therapy from the beginning, because the patients treated at Hammersmith come from far away.
Hypertension
Hypertension is an almost constant feature in Cushing's syndrome and all but one of these (Welbourn 1964) . Before treatment the mean systolic pressure was 45 mmHg, and the mean diastolic 32 mmHg, above the mean for the general population. Nearly half had serious complications before operation and some had atheromatous changes which were clearly irreversible. It is hardly surprising therefore that, although the blood pressure nearly always fell appreciably after operation, one-fifth of the patients died from cardiovascular accidents in the succeeding years and that 2 others have developed angina. In several, however, complications such as myocardial ischxmia and retinopathy have regressed. Fig 1 shows the mean relative blood pressure at two-yearly intervals after operation for the whole series, together with some of the patients treated in the past five years. Within two years of operation the pressure fell to within 5 or 10 mmHg of normal and then remained there for fifteen years.
The average figures, however, conceal the course of events in individual patients. In 70% of those with benign lesionsthe patients who underwent lasting remissionthe pressure fell to normal or near normal and remained there. Occasionally it fell slowly and took about five years to reach normal, and sometimes it tended to rise again later, even without recurrence of the syndrome. In a few, who had been very hyper-tensive indeed, the pressure fell markedly, but still remained high, and in a few others it was never well controlled.
In one patient only, who had had pre-eclamptic toxemia and hypertension before she developed Cushing's syndrome, was the blood pressure higher after adrenalectomy than it had been before.
Pregnancy
Sexual function is usually impaired in Cushing's syndrome and restored after successful treatment. Three women in our series have had 6 pregnancies between them since adrenalectomy and one woman has 3 healthy children. One patient had mild toxemia during one pregnancy, but in all the other pregnancies the blood pressure remained normal. the results are shown annually for five years. For the first 18, who were treated more than ten years ago, the results are shown after ten years andfor the first 8, treated more than fifteen years ago, the results avre shown after fifteen years to five years; so that by then 13, or 60%, remained. Since then only one more patient has diedafter thirteen yearsand the proportions of those alive at ten years and at fifteen years were the same as at five years. All 3 patients with adenomas were alive at five years, while all 4 with carcinomas were dead in one year. Three of the 4 with pituitary tumours initially were dead in three years. The fourth was in remission and well after ten years.
Overall Survival
This, then, is our experience of the natural history of treated Cushing's syndrome. Clearly, the first year after operation is the most hazardous. Thereafter those who survive the first five years have an excellent chance of surviving fifteen years and of leading normal lives.
Dr D A D Montgomery (The Sir George E Clark Metabolic Clinic, Royal Victoria Hospital, Belfast BT12 6BA) said he felt that subtotal adrenalectomy still had a part to play in the treatment of certain cases of Cushing's syndrome due to adrenal hyperplasia, especially if effective follow up could be maintained. While agreeing that the adrenal remnant in such cases often functioned subnormally he thought that in others adrenal function returned to normal and he instanced the case of one young woman who had had a subtotal adrenalectomy sixteen years ago and whose initial subnormal response had now become normal.
Such cases might fall into the category of patients with Cushing's syndrome without pituitary tumours or other structural abnormality in the hypothalamic-pituitary region, whose adrenal hyperplasia possibly resulted from a functional disturbance of the hypothalamicpituitary axis. If so, subtotal adrenalectomy might be an excellent method of treatment, but unfortunately there was no means as yet of detecting such patients during life. Finally, total adrenalectomy was important for control of the features of Cushing's syndrome in those patients with suspected pituitary lesions such as those with full-sized pituitary fosse, but without sufficient evidence to make a definitive diagnosis of pituitary tumour. It is just ten years since Hazard et al. 1959 first described medullary carcinoma of the thyroid as a distinct entity. Williams (1967) added considerably to our knowledge of this tumour. The medullary carcinoma is a solid tumour composed of islands or nests of polygonal cells with clear or eosinophilic granular cytoplasm. A constant feature is the presence of amyloid in variable amounts in the stroma. The tumour, which is slow growing, is derived from parafollicular (C) cells which normally secrete calcitonin, and large quantities of calcitonin have now been found in tumours and in the plasma of patients with medullary carcinoma (Cunliffe et al. 1968 ). Davis (1967) reported that the incidence of medullary carcinoma in a series of 222 patients was 6-8 % and similar incidence has been reported by others.
The histological material from all patients with malignant disease of the thyroid, seen in the Royal Victoria Infirmary since 1960, was examined. The distribution of tumour types is shown in Table 1 . Five patients (7%Y.) were found to have medullary carcinoma. A review of these 5 patients revealed some of the clinical and histological characteristics of this tumour and serum calcitonin levels were measured in 3. The main features of this group of patients are given in Table 2 . Table 1 Varieties of thyroid carcinoma in a series of 69 cases presenting over a period of 10 years 
